CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ÀÌÀ¯È£
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : ½ÅÀåÀ̽Ä/±Þ¼º½ÅÁúȯ/¸¸¼º½ÅÁúȯ/Ç÷´¢/´Ü¹é´¢/Åõ¼®
  • Á÷ À§: Á¶±³¼ö
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßžµ¿ 351¹øÁö
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
34 (±¹¿Ü)SCI 25-hydroxyvitamin D levels and vascular calcification in perdialysis and dialysis patients with chronic kidney disease
33 (±¹³»)KCI ±Ý¼º ½ÅºÎÀüÀ» µ¿¹ÝÇÑ ºÎµ¿È­¿¡ ÀÇÇÑ °íÄ®½·Ç÷Áõ¼º ½ÅÁõ 1¿¹
32 (±¹³»)KCI Æı¹ Ç×ÀÎÁöÁú ÁõÈıº ÀÇÁõ ȯÀÚÀÇ ÆÄÁ¾Ç÷°ü³»ÀÀ°í °ü·Ã ±Þ¼º ½Å¼Õ»ó 1¿¹
31 (±¹³»)KCI Intra-Renal Arterial Pseudoaneurysm Associated with Acute Pyelonephritis
30 (±¹³»)SCI MTHFR C677T polymorphism as a risk factor for vascular calcification in chronic hemodialysis patients
29 (±¹³»)KCI ¿ìÃø ÃÑÀå°ñµ¿¸Æ Ç÷ÀüÁõÀÌ Ãʱâ Áõ»óÀ¸·Î ¹ßÇöµÈ ¸·¼º »ç±¸Ã¼½Å¿° 1¿¹
28 (±¹³»)KCI ±Þ¼º ½ÅºÎÀü°ú Èä¼ö¸¦ µ¿¹ÝÇÑ ¿ø¹ß¼º Èĺ¹¸·°­ ¼¶À¯È­Áõ 1¿¹
27 (±¹³»)±âŸ ºñ´ç´¢º´¼º ¸»±â½ÅºÎÀü ȯÀÚ¿¡¼­ ½ÉÇ÷°üÁúȯ ¹ß»ýÀÇ ¿¹Ãø ÀÎÀڷμ­ ¾ÆµðÆ÷³ØƾÀÇ À¯¿ë¼º
26 (±¹³»)±âŸ ¸¸¼º ½ÅºÎÀü ȯÀÚ¿¡¼­ clopidogrel¿¡ ÀÇÇØ À¯¹ßµÈ È£Áß±¸°¨¼ÒÁõ 1¿¹
25 (±¹³»)KCI °Å´ë ´Ü¼ø ½Å³¶Á¾ÀÇ °æÈ­¿ë¹ý Ä¡·á¸¦ ¹ÞÀº ȯÀÚ¿¡¼­ ¹ß°ßµÈ ½Å¼¼Æ÷¾Ï 1¿¹
ÀÌÀüÆäÀÌÁö À̵¿ 11 12 13 14 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729